Pathfinder Cell Therapy Inc
Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies… Read more
Pathfinder Cell Therapy Inc (PFND) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2015: 0.026x
Based on the latest financial reports, Pathfinder Cell Therapy Inc (PFND) has a cash flow conversion efficiency ratio of 0.026x as of September 2015.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-178.00K) by net assets ($-6.73 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Pathfinder Cell Therapy Inc - Cash Flow Conversion Efficiency Trend (1999–2014)
This chart illustrates how Pathfinder Cell Therapy Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Pathfinder Cell Therapy Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pathfinder Cell Therapy Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Spyglass Resources Corp
PINK:SGLRF
|
0.037x |
|
Odyne Corporation
PINK:ODYC
|
-0.901x |
|
Helmer Directional
PINK:EXLA
|
-0.011x |
|
Avistar Communications Corp
PINK:AVSR
|
0.055x |
|
City Bank
PINK:CTBK
|
N/A |
|
AgriMinco Corp
PINK:ETPHF
|
0.894x |
|
Zane Interactive Publishing Inc
PINK:ZNAE
|
N/A |
|
M Line Hldgs Inc
PINK:MLHC
|
0.008x |
Annual Cash Flow Conversion Efficiency for Pathfinder Cell Therapy Inc (1999–2014)
The table below shows the annual cash flow conversion efficiency of Pathfinder Cell Therapy Inc from 1999 to 2014.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2014-12-31 | $-5.94 Million | $-963.00K | 0.162x | -53.94% |
| 2013-12-31 | $-4.55 Million | $-1.60 Million | 0.352x | -50.45% |
| 2012-12-31 | $-2.85 Million | $-2.02 Million | 0.710x | -78.46% |
| 2011-12-31 | $-707.00K | $-2.33 Million | 3.296x | +148.58% |
| 2010-12-31 | $-973.00K | $-1.29 Million | 1.326x | +130.60% |
| 2009-12-31 | $842.00K | $-3.65 Million | -4.333x | -223.58% |
| 2008-12-31 | $2.90 Million | $-3.89 Million | -1.339x | -5.26% |
| 2007-12-31 | $2.82 Million | $-3.58 Million | -1.272x | -58.56% |
| 2006-12-31 | $3.33 Million | $-2.67 Million | -0.802x | +94.41% |
| 2005-12-31 | $134.00K | $-1.92 Million | -14.343x | -1307.63% |
| 2004-12-31 | $1.48 Million | $-1.50 Million | -1.019x | +98.60% |
| 2003-12-31 | $18.00K | $-1.31 Million | -72.778x | -5166.30% |
| 2002-12-31 | $-630.00K | $-905.00K | 1.437x | +112.86% |
| 2001-12-31 | $-1.34 Million | $-905.00K | 0.675x | +22.27% |
| 2000-12-31 | $-799.00K | $-441.00K | 0.552x | +4.58% |
| 1999-12-31 | $-991.00K | $-523.00K | 0.528x | -- |